Search Results 6191-6200 of 25441 for oral
... oral contraceptives, progestogen or estrogen preparations. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...
... oral regimens (capecitabine). In this trial, both the risk of relapse (hazard ratio: 2.09; 95% CI: 1.38-3.17; p < 0.001) and the risk of death (hazard ratio ...
Epub 2022 Mar 29. View PubMed; Zwart SR, Aunon-Chancellor SM, Heer M, Melin MM, Smith SM. Albumin, oral contraceptives, and venous thromboembolism risk in ...
Investigating tumor growth factors for oral cancer. Evaluating new methods of use for chemotherapy. Evaluating new radiation therapy regimens. Investigating ...
Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric and Adolescent Medicine · Pediatric Hematology/Oncology · Pediatric ...
Research at Mayo Clinic in diabetic nephropathy includes developing new diagnostic and treatment tools, such as oral medicines that may help stop or delay ...
Women of childbearing potential who are not on oral or injectable contraceptives or IUDs and do not consent to practice abstinence for period of 4 weeks. 25 ...
Abdelmoneim YM, Lou Y, Advani P, Khoor A, Sharma A, Parent EE. FES avid pulmonary adenocarcinoma and confounding ER+ breast carcinoma. Radiol Case Rep. 2025 Jan ...
Received treatment of infection with intravenous (within 30 days of baseline) or oral (within 14 days prior to baseline) antibiotics, antivirals, or antifungals ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.